AIRS MEDICAL

Name: AIRS MEDICAL
Brand: AIRS Medical

AIRS Medical is an AI-enabled MRI software platform that accelerates MRI acquisition and performs deep-learning reconstruction/denoising (SwiftMR) while providing quantitative, cross-scanner brain MRI outputs (SwiftSight) that integrate with PACS-based workflows.

Est 2018|Raised $38.3M|62 Ref Customers

Website|FTEs 111|HQ Seoul, South Korea

Published Oct 14, 2026

01Common complaints

If you are a single-vendor scanner shop
- If your environment is exclusively Siemens (or exclusively GE/Philips/Canon) and you already have an accepted vendor-native deep-learning reconstruction license, the incremental value of a third-party vendor-neutral solution may be limited.
If you need fully on-console reconstruction with minimal IT integration
- AIRS Medical describes a PACS/DICOM-style workflow; organizations seeking purely scanner-console-native workflows may prefer vendor-native offerings.
If you require publicly documented security certifications and detailed public security disclosures
- SOC 2 and ISO documentation were not clearly found in the public sources reviewed; highly regulated buyers should request formal security attestations and penetration test reports during procurement.
If your use case relies heavily on niche sequences with uncertain coverage
- Many AI reconstruction tools do not cover all sequence types; buyers with a high proportion of specialized sequences should confirm sequence-level support prior to purchase.
If you require transparent list pricing for rapid purchasing
- Quote-based sales models can extend procurement timelines for small imaging centers.
Current limitations acknowledged by vendor / implied constraints
- The vendor states the product is not commercially available in all countries; availability depends on regional regulatory clearance and local distribution.
- Coverage is determined by the sequences included in each study; protocol-level review is required to confirm support.
Common category limitations (not AIRS-specific, but relevant)
- Sequence support is not universal; certain sequence families may be better supported than others.
- Image appearance and texture changes require reader acceptance testing.
- Scanner software upgrades and protocol drift can necessitate re-validation.
Roadmap / future features
- Vendor release notes reference ongoing additions (e.g., SSO support and viewer enhancements). Public roadmap timelines are not prominently posted; buyers should request a formal roadmap and change control process during procurement.

- If you are a single-vendor scanner shop - If your environment is exclusively Siemens (or exclusively GE/Philips/Canon) and you already have an accepted vendor-native deep-learning reconstruction license, the incremental value of a third-party vendor-neutral solution may be limited. - If you need fully on-console reconstruction with minimal IT integration - AIRS Medical describes a PACS/DICOM-style workflow; organizations seeking purely scanner-console-native workflows may prefer vendor-native offerings. - If you require publicly documented security certifications and detailed public security disclosures - SOC 2 and ISO documentation were not clearly found in the public sources reviewed; highly regulated buyers should request formal security attestations and penetration test reports during procurement. - If your use case relies heavily on niche sequences with uncertain coverage - Many AI reconstruction tools do not cover all sequence types; buyers with a high proportion of specialized sequences should confirm sequence-level support prior to purchase. - If you require transparent list pricing for rapid purchasing - Quote-based sales models can extend procurement timelines for small imaging centers. - Current limitations acknowledged by vendor / implied constraints - The vendor states the product is not commercially available in all countries; availability depends on regional regulatory clearance and local distribution. - Coverage is determined by the sequences included in each study; protocol-level review is required to confirm support. - Common category limitations (not AIRS-specific, but relevant) - Sequence support is not universal; certain sequence families may be better supported than others. - Image appearance and texture changes require reader acceptance testing. - Scanner software upgrades and protocol drift can necessitate re-validation. - Roadmap / future features - Vendor release notes reference ongoing additions (e.g., SSO support and viewer enhancements). Public roadmap timelines are not prominently posted; buyers should request a formal roadmap and change control process during procurement.

Deal disqualifiers (poor fit)

Throughput constrained primarily by staffing or room availability rather than magnet time
Data governance that prohibits cloud processing with no acceptable on-prem/private cloud option
Radiologists require vendor-native reconstruction appearance and will not accept third-party texture changes

Why some customers left for competitors (churn reasons)

No direct, independently verified churn accounts for AIRS Medical were found in the accessible sources. Plausible category-level churn drivers (inferred, not AIRS-specific) include reader preference for vendor-native reconstruction appearance, gaps in sequence coverage, cloud/security concerns, cost considerations, or performance variability.

02Why they buy

Product attributes supported by evidence (with caveats)
- SwiftMR has FDA 510(k) clearances listed in public regulatory records, which can support clinical procurement conversations.
- SwiftMR and the vendor are cited in peer-reviewed publications and systematic reviews that evaluate deep-learning reconstruction approaches in MRI; these references should be reviewed for applicability to local protocols.
- The vendor positions the offering as vendor-neutral with support for multiple major scanner brands, which can be relevant for mixed-fleet deployments.
Differentiation described by vendor but requiring validation
- The vendor's claims of large adoption numbers and "up to 50%" time reductions are vendor-published and should be validated through pilots and reference checks to determine expected local impact.
Areas where competitors may offer advantages
- Vendor-native solutions can offer tighter console integration and scanner-specific optimizations at the cost of potential vendor lock-in.

- Product attributes supported by evidence (with caveats) - SwiftMR has FDA 510(k) clearances listed in public regulatory records, which can support clinical procurement conversations. - SwiftMR and the vendor are cited in peer-reviewed publications and systematic reviews that evaluate deep-learning reconstruction approaches in MRI; these references should be reviewed for applicability to local protocols. - The vendor positions the offering as vendor-neutral with support for multiple major scanner brands, which can be relevant for mixed-fleet deployments. - Differentiation described by vendor but requiring validation - The vendor's claims of large adoption numbers and "up to 50%" time reductions are vendor-published and should be validated through pilots and reference checks to determine expected local impact. - Areas where competitors may offer advantages - Vendor-native solutions can offer tighter console integration and scanner-specific optimizations at the cost of potential vendor lock-in.

Why customers chose this product over alternatives (evidence available)

The vendor emphasizes a vendor-neutral integration approach (compatibility across Siemens, GE, Philips, Canon fleets) and an architecture that does not require scanner hardware replacement; these aspects are positioned by the vendor as procurement enablers.
FDA 510(k) clearances and references in peer-reviewed literature are presented by the vendor and appear in the public literature reviewed, which can support procurement conversations relative to less-documented tools.

- The vendor emphasizes a vendor-neutral integration approach (compatibility across Siemens, GE, Philips, Canon fleets) and an architecture that does not require scanner hardware replacement; these aspects are positioned by the vendor as procurement enablers. - FDA 510(k) clearances and references in peer-reviewed literature are presented by the vendor and appear in the public literature reviewed, which can support procurement conversations relative to less-documented tools.

03Field reports

Review platforms (G2, TrustRadius, Gartner Peer Insights)

Searches encountered naming collisions with unrelated products; no verified listings for AIRS Medical SwiftMR/SwiftSight were found on Gartner Peer Insights or G2 in the accessible results for this research set.
TrustRadius and other review platforms did not yield a confirmed product review page for AIRS Medical SwiftMR in the sources accessible during this review.

Vendor-published testimonials (positive, but vendor-provided)

The vendor publishes testimonials and case-study summaries that report improvements in throughput and perceived image quality. These vendor-published statements cite time-savings and capacity increases. They are useful for understanding vendor positioning but should be validated by prospective buyers via pilot studies or reference checks before relying on them for procurement decisions.
Examples of vendor-published testimonial excerpts observed on vendor pages:
- Reported notable time-savings (vendor-published)
- Reported substantial scan-time reductions (vendor-published)
- A testimonial stating no workflow disruption and reporting benefits observed shortly after installation (vendor-published)

- The vendor publishes testimonials and case-study summaries that report improvements in throughput and perceived image quality. These vendor-published statements cite time-savings and capacity increases. They are useful for understanding vendor positioning but should be validated by prospective buyers via pilot studies or reference checks before relying on them for procurement decisions. - Examples of vendor-published testimonial excerpts observed on vendor pages: - Reported notable time-savings (vendor-published) - Reported substantial scan-time reductions (vendor-published) - A testimonial stating no workflow disruption and reporting benefits observed shortly after installation (vendor-published)

Community/social discussion (more candid; still anecdotal)

Discussions on forums such as Reddit include practitioner comparisons of deep-learning reconstruction options and references to large-scale scanner rollouts by major outpatient providers. These posts indicate market awareness but do not substitute for structured evaluations or independent review data.
Community threads highlight common category observations (not AIRS-specific) such as sequence support limitations and variability in time reductions depending on protocol and sequence type.

- Discussions on forums such as Reddit include practitioner comparisons of deep-learning reconstruction options and references to large-scale scanner rollouts by major outpatient providers. These posts indicate market awareness but do not substitute for structured evaluations or independent review data. - Community threads highlight common category observations (not AIRS-specific) such as sequence support limitations and variability in time reductions depending on protocol and sequence type.

Specific outcomes customers achieved (with metrics when available)

Vendor-published materials include quantified outcomes such as reported increases in patient capacity, improvements in daily scan throughput, and reported capital cost avoidance. These outcomes are vendor-published; methodology and baseline assumptions are not disclosed in the vendor summaries and should be validated locally by buyers through pilots or reference checks.

Vendor case studies surfaced

Vendor materials and case-study pages reference deployments at organizations including 3T Radiology & Research, GK Medical, Invision Sally Jobe, East River Medical Imaging, OrthoSouth, and Dr. Consulta. These case studies summarize operational impacts and reported outcomes.

Quantified business impact (vendor-published)

Vendor-published case studies include reported capacity increases, time savings, and capital-avoidance figures. The vendor materials generally do not disclose baseline protocols, staffing assumptions, schedule constraints, or detailed methodologies for these calculations.
Critical evaluation: reported throughput gains may be constrained by non-scan bottlenecks (patient preparation, staffing, room turnover, radiologist availability), so buyers should consider end-to-end operational factors when estimating achievable impact.

- Vendor-published case studies include reported capacity increases, time savings, and capital-avoidance figures. The vendor materials generally do not disclose baseline protocols, staffing assumptions, schedule constraints, or detailed methodologies for these calculations. - Critical evaluation: reported throughput gains may be constrained by non-scan bottlenecks (patient preparation, staffing, room turnover, radiologist availability), so buyers should consider end-to-end operational factors when estimating achievable impact.

Implementation details and time to value

Vendor testimonials describe rapid installation in some deployments; testimonial language included reports of benefits observed within a short period in at least one customer statement. Buyers should validate such claims through controlled pilots that include:
- Side-by-side image comparisons read by representative radiologists
- Motion and lesion conspicuity checks
- Operational pilots measuring full appointment duration and throughput, not only sequence acquisition time

- Vendor testimonials describe rapid installation in some deployments; testimonial language included reports of benefits observed within a short period in at least one customer statement. Buyers should validate such claims through controlled pilots that include: - Side-by-side image comparisons read by representative radiologists - Motion and lesion conspicuity checks - Operational pilots measuring full appointment duration and throughput, not only sequence acquisition time

Mixed results / failures

No publicly documented failed deployments were identified in the accessible sources. Buyers should request references that include both successful and discontinued deployments, and seek details about reasons for discontinuation where applicable.

04Best fit

Company sizes

Multi-site imaging groups and hospital systems with substantial MRI volume where scanner throughput is a limiting factor for patient access and revenue generation.
Typical fit indicators:
- Multiple scanners per region
- High utilization with appointment backlogs
- Desire to standardize image quality across older and newer magnets

Industries and verticals

Outpatient imaging centers
Hospital radiology departments
Preventive/whole-body MRI clinics (as suggested by vendor case studies)
Research programs interested in cross-scanner reproducibility (SwiftSight use case)

Roles and personas

Economic buyer: VP Imaging, radiology administrator, CFO/COO for outpatient imaging
Technical buyer: PACS administrator, imaging informatics, IT security
Champions/end users: MRI lead technologists, subspecialty radiologists (neuroradiology/MSK/body)

Pain points addressed

Scanner backlogs and long appointment lead times
Patient motion and tolerance issues associated with long scan durations
Capital constraints where groups prefer to increase throughput rather than purchase new scanners
Need for consistent image characteristics across heterogeneous scanner fleets

Qualification criteria (good fit)

Willingness to run a structured pilot with radiologist sign-off
Clear operational constraint where magnet time is the limiting factor (rather than staffing or referral volume)
PACS/DICOM environment capable of supporting routing and QA governance

05The pitch

What the product does (core value proposition in objective terms)

AIRS Medical provides an AI-enabled software platform for MRI that targets two primary outcomes:
- Reduced MRI acquisition time through accelerated acquisition and reconstruction/denoising (SwiftMR)
- Quantitative brain MRI outputs intended to be reproducible across scanner models (SwiftSight)
The vendor presents the product as designed to reduce MRI acquisition time (vendor-claimed substantial reductions) and to modify image appearance in ways intended to maintain or improve diagnostic acceptability, while integrating with existing PACS-based workflows and mixed-vendor MRI fleets.
The vendor reports adoption metrics; vendor-published claims indicate broad uptake across many institutions, multiple countries, and millions of MRI exams annually. These adoption metrics are vendor-claimed and were not independently verified in the sources reviewed for this report.

- AIRS Medical provides an AI-enabled software platform for MRI that targets two primary outcomes: - Reduced MRI acquisition time through accelerated acquisition and reconstruction/denoising (SwiftMR) - Quantitative brain MRI outputs intended to be reproducible across scanner models (SwiftSight) - The vendor presents the product as designed to reduce MRI acquisition time (vendor-claimed substantial reductions) and to modify image appearance in ways intended to maintain or improve diagnostic acceptability, while integrating with existing PACS-based workflows and mixed-vendor MRI fleets. - The vendor reports adoption metrics; vendor-published claims indicate broad uptake across many institutions, multiple countries, and millions of MRI exams annually. These adoption metrics are vendor-claimed and were not independently verified in the sources reviewed for this report.

Target market and market positioning

Primary buyers/users (per vendor messaging and workflow descriptions)
- Radiologists (diagnostic confidence, image quality)
- MRI operations/technologists (throughput, shorter protocols)
- Imaging leadership (fleet standardization, ROI / capital avoidance)
Market category
- MRI post-processing / reconstruction acceleration (vendor-neutral deep learning reconstruction)
- Quantitative imaging / neuro measurement software (SwiftSight)

- Primary buyers/users (per vendor messaging and workflow descriptions) - Radiologists (diagnostic confidence, image quality) - MRI operations/technologists (throughput, shorter protocols) - Imaging leadership (fleet standardization, ROI / capital avoidance) - Market category - MRI post-processing / reconstruction acceleration (vendor-neutral deep learning reconstruction) - Quantitative imaging / neuro measurement software (SwiftSight)

Get a comprehensive analysis of AIRS MEDICAL including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →